Aligos Therapeutics rises after $105 million private placement

Aligos Therapeutics

12/02/2025 12:43

** Shares of biotech firm Aligos Therapeutics  ALGS.O  rise
3.8% to $27 premarket
    ** ALGS says it is raising $105 million in a private
placement financing 
    ** Co is selling ~2.1 million shares of common stock along
with warrants to purchase up to ~2 million additional shares at
a combined purchase price of $26.0825/shr
    ** Combined purchase price is at a 0.2% premium to the
stock's last close
    ** Co says the funding will be used to start a mid-stage
trial for ALG-000184, a treatment for chronic hepatitis B virus
infection
    ** Co says the funding will extend its cash runway into the
H2 of 2026
    ** Co has 3.6 million outstanding shares, with market cap of
$93.4 million - LSEG data
    ** Jefferies and Piper Sandler are acting as placement
agents
    ** ALGS shares more than doubled in 2024

 (Reporting by Kamal Choudhury in Bengaluru)
 ((Kamal.Choudhury@thomsonreuters.com;))